Medtronic announces Board appointments and shareholder value creation initiatives to advance strategic priorities
Experienced executives John Groetelaars and Bill Jellison appointed to the Board of Directors Board forms new Growth and Operating committees to sharpen focus on the company's ongoing strategic portfolio management, operational execution and capital allocation Plan to host Investor Day in...
Related Questions
How will the appointment of John Groetelaars and Bill Jellison to the Board influence Medtronic's strategic execution and governance?
What impact will the creation of the new Growth and Operating committees have on the company's operational performance and capital allocation?
Will the upcoming Investor Day provide new guidance or metrics that could affect Medtronic's stock valuation and price momentum?